Family Office Of America (FOFA) Receivables (2025 - 2026)
Family Office Of America's (FOFA) quarterly Receivables came in at $267666.0 in Q1 2026, up 258.01% quarter-over-quarter from $74764.0 in Q4 2025.
Family Office Of America (FOFA) Receivables (2025 - 2026) Analysis & Trends
Family Office Of America has disclosed Receivables across 2 years of filings, most recently posting $267666.0 for Q1 2026.
- Receivables for Q1 2026 came in at $267666.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $267666.0 (changed N/A YoY), and the FY2025 annual result was $74764.0, changed N/A from the prior year.
- Receivables came in at $267666.0 for Q1 2026 at Family Office Of America, up from $74764.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $267666.0 in Q1 2026 to a low of $74764.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 1.09 Bn |
| 10 | Family Office Of America | - | - | 783,126.00 | 267,666.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 267,666.00 |
| Dec 31, 2025 | 74,764.00 |